Português
- 01
AbbVie Inc.
ABBVNova Iorque
$504 bi
+0.5% 1W·+24.3% 1Y
- 02
F. Hoffmann-La Roche AG
ROGSIX
$372 bi
-0.6% 1W·— 1Y
- 03
Novo Nordisk A/S
NVONova Iorque
$170 bi
+2.5% 1W·-24.5% 1Y
- 04
Vertex Pharmaceuticals Inc.
VRTXNasdaq
$127 bi
+5.2% 1W·+19.9% 1Y
- 05
Companhia Bristol-Myers Squibb (BMS)
BMYNova Iorque
$122 bi
+3.1% 1W·+37.0% 1Y
- 06
WuXi AppTec Co., Ltd.
02359Hong Kong
$75.9 bi
-9.3% 1W·+93.5% 1Y
- 07
Lonza Group AG
LONNSIX
$51.2 bi
+6.5% 1W·+5.0% 1Y
- 08
Bayer AG
BAYNXetra
$49.1 bi
-0.8% 1W·+59.8% 1Y
- 09
Jiangsu Hengrui Pharmaceuticals
600276Xangai
$46.4 bi
-1.3% 1W·-23.6% 1Y
- 10
Ipsen S.A.
IPNEuronext
$13.8 bi
+4.7% 1W·+25.6% 1Y
- 11
China National Biotec Group
600161Xangai
$3.7 bi
-1.7% 1W·— 1Y
- 12
Sarepta Therapeutics Inc.
SRPTNasdaq
$1.8 bi
+10.3% 1W·-24.0% 1Y
- 13
Vetoquinol
VETOEuronext
$1 bi
+1.7% 1W·-4.2% 1Y
Exibindo 1–13 de 13